Table 2

Constitutive and stimulated cytokine production by primary type II alveolar epithelial cells

 Stimulant
BasalStaphylococcus aureus
PGN
S. aureus LTAPseudomonas aeruginosa
LPS
CpGTNF
IL-1β (pg/mL)5
2.5–8
17.2 **
5–152
3.4
1.6–12.5
6.3
2.2–14
7.5
1.7–11
11
1.2–85.3
IL-6 (pg/mL)236
8.3–1276
927 *
121–9060
333
7.6–716
214
8.2–533
228
12.6–803
1205**
34.1–4029
IL-8 (pg/mL)2273
707–11 226
7444 *
1283–100 000
2002
843–21 914
1507
649–13 548
2919
636–40 775
31 721 ***
9450–78 198
IL-10 (pg/mL)15
2.6–1276
25.4 **
3.5–5000
23.2
3.6–716
19.2
3–504
20.2
0–803
26 *
3.5–4029
IL-12 (pg/mL)8
5.4–19.7
7.3
6.6–31.2
8.3
4.9–30
12.7
3.5–25
12.0
2.7–28.6
7
2.7–30.3
TNF (pg/mL)10
3.6–21.2
29 *
6.5–279
5
0–21.4
12
2.3–26.7
7.0
0–15.7
  • Data are expressed as median (upper line, italic) and range (lower line, normal text). n=7 for all conditions. PGN and LTA were applied at 10 μg/mL, LPS at 100 ng/mL, CpG at 1 μM and TNF at 10 ng/mL. Statistical analysis was by Friedman's test and Dunn's post hoc test. *p<0.05, **p<0.01, ***p<0.001 relative to basal levels, by Dunn's post hoc test.

  • †TNF was used as a positive control; TNF was not measured in TNF-stimulated cells.

  • IL, interleukin; LPS, lipopolysaccharide; LTA, lipoteichoic acid; TNF, tumour necrosis factor; PGN, peptidoglycan.